The objective of the current research project is, by using high quality Swedish registry data, to evaluate use, tolerance and effect of anti-fibrotic drugs in IPF-patients. Secondary study objectives are to determine the clinical profile, determinants of treatment adherence, long-term safety and to describe the patient journey from the first sign of disease to end of treatment.
Study Type
OBSERVATIONAL
Enrollment
400
The real-Life use of anti-fibrotic drugs in patients with idiopathic pulmonary fibrosis in Sweden
Karolinska University Hospital
Stockholm, Sweden
RECRUITINGAnti-fibrotic drugs among the patients recorded in the Swedish IPF-registry
The use of anti-fibrostic drugs
Time frame: 2014-2020
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.